rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

NewcelX Ltd. -

NCEL · Nasdaq

Health CareBiotechnologyNot moving yet

NCEL stood above a rising 150-day average in 9 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 22.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 5
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$750K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
3 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$723KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Michel RevelCSO and Directorbought54,545at $2.7527 Apr 2026filed 29 Apr 2026
Michel RevelCSO and Directorbought76,36327 Apr 2026filed 29 Apr 2026
Olivier SamuelDirectorbought81,818at $2.7527 Apr 2026filed 29 Apr 2026
Olivier SamuelDirectorbought114,54527 Apr 2026filed 29 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders3-1 on the quarter
New · exited1 · 2
Reported value$2,592

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JONES FINANCIAL COMPANIES LLLPnew · filed 14 Aug 2026700$2,548+700
Caitong International Asset Management Co., Ltdadded · filed 5 Aug 20269$33+8+800.0%
CoreCap Advisors, LLCunchanged · filed 6 Jul 20263$1100.0%
31 Dec 2025 – 30 Jun 2026
134Dec 25Mar 26Jun 26

Everyone who traded it

Michel Revel Company insiderCSO and Director · last 27 Apr 20261 · 0
Olivier Samuel Company insiderDirector · last 27 Apr 20261 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-35.3%
Debt to equityFY 2025 · to 31 Dec 20250.05×
Share count trendFY 2025 · to 31 Dec 202551.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$2.2M
Free cash flowFY 2025 · to 31 Dec 2025−$2.8M

Analyst forecasts

No analyst forecasts yet.